525 related articles for article (PubMed ID: 17634972)
21. Repeated confidence intervals for adaptive group sequential trials.
Mehta CR; Bauer P; Posch M; Brannath W
Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
[TBL] [Abstract][Full Text] [Related]
22. [Aspects of sample size determination and power calculation illustrated on examples from rehabilitation research].
Kutschmann M; Bender R; Grouven U; Berg G
Rehabilitation (Stuttg); 2006 Dec; 45(6):377-84. PubMed ID: 17123220
[TBL] [Abstract][Full Text] [Related]
23. Test for the consistency of noninferiority from multiple clinical trials.
Yan X; Wang MC; Su X
J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
[TBL] [Abstract][Full Text] [Related]
24. Adaptive statistical analysis following sample size modification based on interim review of effect size.
Hung HM; Cui L; Wang SJ; Lawrence J
J Biopharm Stat; 2005; 15(4):693-706. PubMed ID: 16022173
[TBL] [Abstract][Full Text] [Related]
25. Are flexible designs sound?
Burman CF; Sonesson C
Biometrics; 2006 Sep; 62(3):664-9; discussion 670-83. PubMed ID: 16984302
[TBL] [Abstract][Full Text] [Related]
26. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
Li B; Grambsch P
Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
[TBL] [Abstract][Full Text] [Related]
27. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
Dilba G; Bretz F; Hothorn LA; Guiard V
Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
[TBL] [Abstract][Full Text] [Related]
28. Optimal two-stage designs allowing flexibility in number of subjects for phase II clinical trials.
Masaki N; Koyama T; Yoshimura I; Hamada C
J Biopharm Stat; 2009 Jul; 19(4):721-31. PubMed ID: 20183436
[TBL] [Abstract][Full Text] [Related]
29. Sample size determination for alternate periods of use study designs with binary responses.
Morel JG; Neerchal NK
J Biopharm Stat; 2012; 22(2):351-67. PubMed ID: 22251179
[TBL] [Abstract][Full Text] [Related]
30. Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.
Wassmer G
J Biopharm Stat; 2003 Nov; 13(4):585-603. PubMed ID: 14584710
[TBL] [Abstract][Full Text] [Related]
31. Consultants' forum: should post hoc sample size calculations be done?
Walters SJ
Pharm Stat; 2009; 8(2):163-9. PubMed ID: 18416448
[TBL] [Abstract][Full Text] [Related]
32. Efficient group sequential designs when there are several effect sizes under consideration.
Jennison C; Turnbull BW
Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
[TBL] [Abstract][Full Text] [Related]
33. Optimal conditional error functions for the control of conditional power.
Brannath W; Bauer P
Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
[TBL] [Abstract][Full Text] [Related]
34. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
Dann RS; Koch GG
Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
[TBL] [Abstract][Full Text] [Related]
35. The reassessment of trial perspectives from interim data--a critical view.
Bauer P; Koenig F
Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
[TBL] [Abstract][Full Text] [Related]
36. The need for more efficient trial designs.
Golub HL
Stat Med; 2006 Oct; 25(19):3231-5; discussion 3313-4, 3326-47. PubMed ID: 16819752
[TBL] [Abstract][Full Text] [Related]
37. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
Jahn-Eimermacher A; Hommel G
Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
[TBL] [Abstract][Full Text] [Related]
38. An algorithm for the design of group sequential triangular tests for single-arm clinical trials with a binary endpoint.
McWilliams TP
Stat Med; 2010 Nov; 29(27):2794-801. PubMed ID: 20860065
[TBL] [Abstract][Full Text] [Related]
39. Testing and estimation in flexible group sequential designs with adaptive treatment selection.
Posch M; Koenig F; Branson M; Brannath W; Dunger-Baldauf C; Bauer P
Stat Med; 2005 Dec; 24(24):3697-714. PubMed ID: 16320264
[TBL] [Abstract][Full Text] [Related]
40. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
